After my ischemic stroke, my neurologist explained I would likely be on a Statin and clopidogrel (Plavix) for the rest of my life. Studies have show that both medications result in lower recurrence of stroke, even in patients with appropriate cholesterol levels.
That’s fine. The Statin isn’t giving me any problems so one more daily pill to reduce the likelihood of another stroke in a statistically significant amount is worth it.
Now a recent study shows there may be an added benefit. Statins appear to minimize the impact of osteoporosis and reduce bone fractures after stroke.
Adults prescribed statin therapy after a stroke were less likely to sustain a fracture vs. similar patients not prescribed statin therapy, according to findings from a population-based study conducted in Taiwan.
“Stroke is a major risk factor for osteoporosis and fractures, owning to a significant loss of bone mineral density, gait disability, balance impairment, immobilization and increase in fall risk that occur after a stroke,” Shu-Man Lin, MD, of the department of physical medicine and rehabilitation at Buddhist Tzu Chi General Hospital in Hualien, Taiwan, and colleagues wrote in the study background. “Fractures, which are a common complication of stroke, can further reduce functional recovery, prolong disability and increase the mortality risk among stroke patients. Thus, it is imperative to develop strategies for osteoporosis and fracture prevention among stroke survivors.”
You can read more details about the study in this article or find the paper here.Click To Tweet